BRNS
Barinthus Biotherapeutics
BRNS
BRNS
15 hedge funds and large institutions have $9.15M invested in Barinthus Biotherapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
3
Increased
2
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$36.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$25.9K |
| 3 |
Renaissance Technologies
New York
|
+$584 |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$356 |
Top Sellers
| 1 |
GS
Gilead Sciences
Foster City,
California
|
-$244K |
| 2 |
IIM
Ipswich Investment Management
Beverly,
Massachusetts
|
-$21.2K |
| 3 |
Millennium Management
New York
|
-$13.2K |
| 4 |
CCG
Catalina Capital Group
Torrance,
California
|
-$12.3K |
| 5 |
Morgan Stanley
New York
|
-$6.95K |
